News
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...
17h
Press Trust of India on MSNSun Pharma shares climb nearly 3 pcShares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for ...
MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation ...
19h
Capital Market on MSNSun Pharma launches Leqselvi in US; settles litigation with Incyte CorpThe drug is indicated for the treatment of alopecia areata - a condition in which the immune system attacks hair follicles, ...
India's equity indices ended a four-session decline, as inflation data came in lower than anticipated, increasing hopes for ...
17h
Capital Market on MSNBulls take the wheel as inflation cools, Nifty cruises past 25,195Equity benchmarks ended a four-day losing streak with modest gains on Tuesday, as easing CPI inflation lifted investor sentiment. Hopes of a potential rate cut spurred buying interest, pushing all NSE ...
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
Shares of HDFC Life Insurance, HDB Financial, ICICI Lombard, Just Dial will remain in focus as companies will declare Q1 ...
Foreign investors turned net buyers in Indian equities on Tuesday after heavy selling a day prior, while domestic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results